Top Abstracts with Expert Perspective: Myeloid Malignancies and Bone Marrow Failure Syndromes
Tracks
-
| Tuesday, April 21, 2026 |
| 8:30 AM - 10:00 AM |
| Hall 1B, Upper Level |
Speaker
Dr Priya Sriskandarajah
Consultant
Guys and St Thomas' NHS Foundation Trust
Session Chair
Dr Giovanna Mantica
Phd Student
University of Cambridge
DNMT3A-R882 mutations intrinsically drive dysfunctional neutropoiesis from human haematopoietic stem cells
8:30 AM - 8:45 AM
Dr Rupen Hargreaves
Clinical Research Fellow
University of Oxford
Myeloproliferative Neoplasms and Thrombosis – a UK Multi-Centre Retrospective Study
8:45 AM - 9:00 AM
Dr Michael Luong
Haematology Clinical Fellow and Specialist Registrar (SpR)
University College London Hospitals NHS Foundation Trust
Myelodysplastic/myeloproliferative overlap neoplasms: Clinicopathological features, treatment strategies, and outcomes — a UK multicentre cohort Study
9:00 AM - 9:15 AM
Dr David Palmer
Haematology Research Fellow
Brighton and Sussex Medical School
RUNX1 aberrations in Blast-Phase CML induce SPATS2L driving Growth, Survival and Therapeutic Resistance through Stress-Granules
9:15 AM - 9:30 AM
Miss Caitlin Roger
Medical Student
University of Edinburgh
Spontaneous Remissions in Paroxysmal Nocturnal Haemoglobinuria (PNH): True Remission or Clonal Evolution to Malignancy?
9:30 AM - 9:45 AM
Dr Patrick Harrington
Consultant Haematologist
Guy's and St Thomas' NHS Foundation Trust
Deprivation is associated with increased risk of death in patients with myeloproliferative neoplasms
9:45 AM - 10:00 AM